对于生物医药行业来讲，专利的保护一直是保护产品市场的关键因素。随着国内企业将眼光更多投向海外，不同国家市场的知识产权规定也将在其中发挥越来越重要的作用。从仿制药到创新药，从对专利认识不清到适应国际法规，医药企业需要有更多的考量。

近年来，随着我国高血压教育和用药水平的提高，多数老年人的高血压管理有了一定改善，客观上推动了我国高血压治疗市场的平稳增长。但是高血压年轻化的发展趋势，导致我国高血压患病率明显上升。数据显示， 2016 年中国高血压用药已超过 800 亿元的市场规模，同比上一年增长 13%。在医疗保障体系日趋完善下，城市公立医院、县级公立医院、城市社区、乡镇卫生院已成为降血压用药的主体市场，钙拮抗剂（ CCB）、血管紧张素受体拮抗剂（ ARB）和复方降压药物 3 个亚类已构成了鼎足之势。根据 HDM 系统数据， 2016 年国内 16 个重点城市公立医院高血压用药市场达到 49.55 亿元，同比上一年增长 6.32%，占据心血管药物用药的 1/3。其中沙坦类药物居于第一位，占据 38.25%的比重。

Digestive enzymes are substances produced by a human body that aid in digestion of food. In cases of individuals, where there are insufficient enzymes, digestive enzyme supplements are consumed to assist digestion.The market includes distribution channels such as online and retail stores, while the different geographical segments considered are the Americas, EMEA, and APAC.The global digestive enzyme supplements market is growing steadily primarily due to the growing consumer awareness about complications that arise from digestive disorders such as abdominal wall hernia, chronic constipation, diverticular disease,hemorrhoids, inflammatory bowel disease, gastroesophageal reflux disease, peptic ulcers, and pancreatitis. Individuals with these disorders require essentials supplements such as digestive enzyme to regularize digestions; the disorders could have arisen because of lifestyle and dietary factors. Apart from the presence of a digestive disorder, increased awareness about the need for good health is also anticipated to positively impact the growth of the market during the forecast period.

HLA typing is performed as a pre-transplant procedure to assess graft rejection. It is a molecular diagnostic technique, which can help to analyze the HLA molecules (Class I & II) by incorporating advanced methods such as next-generation sequencing (NGS).The market sizing includes the revenue generated by the sales of products such as systems, assays, and accessories. It does not contain HLA typing service-related revenue. However, in the report, few key HLA typing service companies are mentioned.Based on the product, the market is divided into: Systems, assays, and instruments.Based on the technology, the market is divided into: PCR-RFLP, PCR-SSO, PCR-SSP, and PCR-SBT.Based on end-user segment, the market is divided into: Hospitals and transplant centers and donor registries and research laboratories.

Hydrocephalus is the abnormal accumulation of CSF within the brain cavities called ventricles (space near the spine). It occurs due to an imbalance in the formation and absorption rate of the fluid. This results in ventricle enlargement and increasedpressure inside the head.CSF produced in the ventricles is circulated throughout the body through ventricular system into the subarachnoid space that is absorbed into the venous system or the bloodstream. CSF production is approximately 0.2 ml/min to 0.4 ml/min or 500 ml to 600ml per day.

The mAbs remain the most favored and hence, the fastest-growing segment of the global protein therapeutics market. Considering their wide offerings ranging from rare diseases to generic and chronic ones, the vendors find immense growth opportunities to be tapped in the segment. Because of this, since the launch of the first mAb in 1986, the protein therapeutics market at present witnesses the availability of many antibodies ranging from oncology indications to autoimmune diseases as well as rare diseases like hemophilia and cystic fibrosis.

Chemical peel, also known as chemosurgery, chemical resurfacing, or chemoexfoliation, consists of applying one or more caustic agents to the skin in order to bring about the controlled destruction of the epidermis and its re-epithelialization.Chemical peeling is of three types: superficial, medium, and deep peeling. The demand for chemical peel will increase in the future, with the rise in preference for home treatment. The demand for acid peel using a gentle, over the counter formula at low concentrations is increasing.

Hypercalcemia refers to the condition where too much calcium enters the extracellular fluid or when there is insufficient calcium excretion from the kidneys. The cases of hypercalcemia are mainly caused by malignancy or hyperparathyroidism.Hypercalcemia is an outcome of overactive parathyroid glands. These four tiny glands are located near thyroid gland and each of them are about the size of a rice grain. The causes of hypercalcemia are some medications, and excessive use of calcium and vitamin D supplements.The global hypercalcemia treatment market is expected to benefit from the growing incidence of chronic conditions that cause spasticity and spasms. Some of these conditions include multiple sclerosis and cerebral palsy. This has driven vendors to conduct R&D, thereby driving the market growth.

Intravenous access is a way to quickly restore iron in the blood stream using a small tube that contains iron drugs.The market encompasses various types of iron drugs such as ferric carboxymaltose,sucrose, dextran, and others.The global intravenous iron drugs market is expected to benefit from the rising incidence of iron deficiency anemia and increase in risk factors that cause iron deficiency such as kidney disorders. Kidney diseases cause iron deficiency due to the lowered production of erythropoietin, which reduces the red blood cell count. For instance, according to the Centers for Disease Control and Prevention (CDC) 2014 statistics, more than 20 million individuals have chronic kidney diseases in the US.However, the number of individuals with diagnosed kidney disease was only 4.5 million in the same year. Therefore, there is an increased need to develop effective therapeutics for the treatment of iron deficiency.

Clinical chemistry analyzers are used for the analysis of samples such as blood,serum, and urine for the detection of analytes. These analyzers are used to detect and measure protein, enzyme, and electrolyte levels present in the sample. The measurement is based on the techniques such as photometric and colorimetric testing, potentiometry, and agglutination.The global clinical chemistry analyzers market is expected to grow at a steady rate during the forecast period. The factors like increasing older population, and rising incidence and prevalence of diabetes, renal diseases, and infections are driving the market. However, the market growth is affected by the growing use of integrated analyzers, which are used to detect various infectious diseases and analytes.